Apricus Biosciences (APRI) Announces National Phase Approval For Vitaros® In Luxembourg
4/3/2014 8:20:44 AM
SAN DIEGO, April 3, 2014 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq:APRI), a pharmaceutical company focusing on the development and commercialization of novel therapeutics for men's and women's health, today announced that the Ministry of Health of Luxembourg has granted national phase approval to Vitaros®, Apricus' novel topical on-demand treatment for erectile dysfunction ("ED").
Help employers find you! Check out all the jobs and post your resume.
comments powered by